These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect. Pauluhn J Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122 [TBL] [Abstract][Full Text] [Related]
6. In vitro assays and biomarkers for drug-induced phospholipidosis. Monteith DK; Morgan RE; Halstead B Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389 [TBL] [Abstract][Full Text] [Related]
7. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations. Tashiro Y; Watanabe Y; Enomoto Y Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720 [TBL] [Abstract][Full Text] [Related]
8. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs. Ohmiya Y; Angevine LS; Mehendale HM Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791 [No Abstract] [Full Text] [Related]
9. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat]. Lageron A; Saffroy M Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854 [TBL] [Abstract][Full Text] [Related]
10. [Phospholipidosis of the rat lung following administrations of chlorimipramine]. Gremigni D; Vannelli G; Sgaragli G; Della Corte L Arch Ital Anat Embriol; 1981; 86(1-2):37-53. PubMed ID: 7316635 [No Abstract] [Full Text] [Related]
11. A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red. Halstead BW; Zwickl CM; Morgan RE; Monteith DK; Thomas CE; Bowers RK; Berridge BR J Appl Toxicol; 2006; 26(2):169-77. PubMed ID: 16278808 [TBL] [Abstract][Full Text] [Related]
12. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Rudmann DG; McNerney ME; VanderEide SL; Schemmer JK; Eversole RR; Vonderfecht SL Toxicol Pathol; 2004; 32(3):326-32. PubMed ID: 15204974 [TBL] [Abstract][Full Text] [Related]
14. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase. Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623 [TBL] [Abstract][Full Text] [Related]
15. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells. Xu FY; Queen G; Brandes L; Hatch GM Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231 [TBL] [Abstract][Full Text] [Related]
16. [Clinical and experimental studies on phospholipidosis caused by diethylaminoethoxyhexestrol(DH)]. Tsujii T; Matsumori T; Takahashi M; Sugioka T; Matsui T Saishin Igaku; 1971 Nov; 26(11):2242-50. PubMed ID: 5141966 [No Abstract] [Full Text] [Related]
17. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages. McCloud CM; Beard TL; Kacew S; Reasor MJ Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587 [TBL] [Abstract][Full Text] [Related]